Financials
- Market Capitalization 41.3 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-13.39
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 214 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 764.51 USD | +2.41% | +4.74% | -3.11% | +38.50% | 78.71 B USD | ||
| 310 | ARGX argenx SE - American Depositary Shares | 817.99 USD | -0.85% | -10.54% | -18.57% | +2.67% | 50.62 B USD | ||
| 443 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 228.35 USD | -1.86% | +3.83% | -8.72% | -49.94% | 30.56 B USD | ||
| 497 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 57.27 USD | +0.60% | +1.27% | -2.37% | +53.70% | 25.58 B USD |